KR100806695B1 - 색소화 질환 치료용 세포치료 약제학적 조성물 - Google Patents
색소화 질환 치료용 세포치료 약제학적 조성물 Download PDFInfo
- Publication number
- KR100806695B1 KR100806695B1 KR1020060037022A KR20060037022A KR100806695B1 KR 100806695 B1 KR100806695 B1 KR 100806695B1 KR 1020060037022 A KR1020060037022 A KR 1020060037022A KR 20060037022 A KR20060037022 A KR 20060037022A KR 100806695 B1 KR100806695 B1 KR 100806695B1
- Authority
- KR
- South Korea
- Prior art keywords
- melanocytes
- cells
- keratinocytes
- fibroblasts
- pigmentation
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
- C12N5/0698—Skin equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
- C12N2502/091—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells melanocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
- C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (11)
- 멜라닌세포, 각질세포 및 섬유아세포를 유효성분으로 포함하며, 상기 섬유아세포의 수는 1 x 103 - 1 x 107 cells/cm2인 색소화 질환 (pigmentation disorders)의 치료용 세포치료 (cell therapy) 약제학적 조성물.
- 제 1 항에 있어서, 상기 멜라닌세포, 각질세포, 섬유아세포 또는 멜라닌세포, 각질세포와 섬유아세포는 체외 분리 또는 체외 분리 후 배양된 것을 특징으로 하는 색소화 질환의 치료용 세포치료 약제학적 조성물.
- 제 1 항에 있어서, 상기 색소화 질환은 저색소화증 (hypopigmentation), 부분 백피증 (piebaldism), 점상 백피증 (leukoderma), 화학물질에 의한 백피증(leukoderma), 백색 비강진 (piryriasis alba), 탈색소 모반, 염증 후 탈색증 또는 백반증인 것을 특징으로 하는 색소화 질환의 치료용 세포치료 약제학적 조성물.
- 제 1 항에 있어서, 상기 조성물에서 상기 멜라닌세포의 수는 1 x 103 - 1 x 106 cells/cm2이고, 상기 각질세포의 수는 1 x 104 - 1 x 107 cells/cm2 이고, 상기 섬유아세포의 수는 1 x 103 - 1 x 106 cells/cm2인 것을 특징으로 하는 색소화 질환의 치료용 세포치료 약제학적 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20050113287 | 2005-11-25 | ||
KR1020050113287 | 2005-11-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070110013A Division KR20070108846A (ko) | 2007-10-31 | 2007-10-31 | 색소화 질환 치료용 세포치료 약제학적 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070055309A KR20070055309A (ko) | 2007-05-30 |
KR100806695B1 true KR100806695B1 (ko) | 2008-02-27 |
Family
ID=38067372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060037022A KR100806695B1 (ko) | 2005-11-25 | 2006-04-25 | 색소화 질환 치료용 세포치료 약제학적 조성물 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100806695B1 (ko) |
CN (2) | CN101351217A (ko) |
WO (1) | WO2007061168A1 (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2928654B1 (fr) * | 2008-03-17 | 2018-04-27 | L'oreal | Equivalent de peau pigmentee fonctionnelle. |
CA2658074C (fr) | 2008-03-17 | 2017-11-07 | L'oreal | Equivalent de peau pigmentee fonctionnelle |
WO2011142588A2 (ko) * | 2010-05-11 | 2011-11-17 | (주)메디컬그룹베스티안 | 피부결함의 완화 또는 치료를 위한 자가피부세포치료제의 제조방법 |
KR101431883B1 (ko) * | 2011-11-24 | 2014-08-21 | 경희대학교 산학협력단 | 동물실험 대체를 위한 3차원 인공 조직 및 모니터링 세포의 공동배양 시스템 및 이의 제조방법 |
CN103983762A (zh) * | 2013-02-08 | 2014-08-13 | 北京富龙康泰生物技术有限公司 | 含黑色素细胞的皮肤模型、其构建方法及用途 |
CN104877957B (zh) * | 2014-02-28 | 2018-06-01 | 上海尚瑞生物医药科技有限公司 | 一种促进黑色素细胞色素产生的细胞株 |
EP3200683A4 (en) * | 2014-09-29 | 2018-03-21 | ELC Management LLC | Actives for stimulating differentiation of keratinocytes to lighten hyperpigmented skin |
ES2625768T3 (es) * | 2015-03-26 | 2017-07-20 | Université De Bordeaux | Método de reconstrucción de piel |
WO2016151134A1 (fr) * | 2015-03-26 | 2016-09-29 | Université De Bordeaux | Équivalent de peau et utilisation |
CN105112353A (zh) * | 2015-07-29 | 2015-12-02 | 赫柏慧康生物科技无锡有限公司 | 角质细胞和黑素细胞混合培养的方法及应用 |
FR3054449B1 (fr) * | 2016-07-29 | 2018-08-31 | L'oreal | Equivalent de peau a compartiments dermiques juxtaposes distincts |
EP3336175B1 (en) * | 2016-12-16 | 2023-08-30 | Universite De Bordeaux | Three-dimensional model of depigmenting disorder |
SG11202105106VA (en) * | 2018-11-30 | 2021-06-29 | Shiseido Co Ltd | Pigmentation skin model and method for producing same, and method for evaluating factor for treating or preventing pigmentation of skin |
JPWO2020111271A1 (ja) * | 2018-11-30 | 2021-10-14 | 株式会社 資生堂 | 皮膚の色素沈着を治療または予防するための組成物 |
CN110257327A (zh) * | 2019-06-27 | 2019-09-20 | 重庆市细胞生物工程技术有限公司 | 一种脐带间充质干细胞的分离培养方法 |
CN114686420B (zh) * | 2022-04-08 | 2023-11-28 | 济南磐升生物技术有限公司 | 一种3d表皮模型的制备方法及应用 |
-
2006
- 2006-04-25 KR KR1020060037022A patent/KR100806695B1/ko active IP Right Grant
- 2006-06-20 CN CNA2006800503254A patent/CN101351217A/zh active Pending
- 2006-06-20 CN CN201310231829.8A patent/CN103356701B/zh not_active Expired - Fee Related
- 2006-06-20 WO PCT/KR2006/002366 patent/WO2007061168A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
Pigment. Cell. Res. 14, 116-125, 2001년 |
Also Published As
Publication number | Publication date |
---|---|
CN103356701B (zh) | 2016-08-31 |
CN103356701A (zh) | 2013-10-23 |
WO2007061168A1 (en) | 2007-05-31 |
CN101351217A (zh) | 2009-01-21 |
KR20070055309A (ko) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100806695B1 (ko) | 색소화 질환 치료용 세포치료 약제학적 조성물 | |
KINIKOGLU et al. | Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering | |
Michel et al. | Characterization of a new tissue-engineered human skin equivalent with hair | |
ES2252259T3 (es) | Modelo de piel tridiminsional. | |
US9764064B2 (en) | Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations | |
JP2000508922A (ja) | 間葉幹細胞を用いる皮膚再生 | |
KR20120120971A (ko) | 인간 다능성 줄기 세포로부터 인간 멜라닌세포를 제조하는 방법 | |
EP4123014A1 (en) | Cardiac organoid, manufacturing method therefor, and method for evaluating drug toxicity by using same | |
US9592257B2 (en) | Complete human skin organ generated from culture-expanded cells | |
US20110321180A1 (en) | Compositions and methods to generate pilosebaceous units | |
CN107683148B (zh) | 皮肤重建方法 | |
US20170252377A1 (en) | Compositions and methods for producing reconstituted skin | |
US20030202965A1 (en) | Methods and compositions for the preparation of cell transplants | |
RU2320720C2 (ru) | Способ культивирования фибробластов для заместительной терапии | |
AU738028B2 (en) | Dermal sheath tissue in wound healing | |
KR20070108846A (ko) | 색소화 질환 치료용 세포치료 약제학적 조성물 | |
JP2017113030A (ja) | 再構成頭皮モデルおよび活性分子のスクリーニング方法 | |
Moulin et al. | In vitro culture methods of skin cells for optimal skin reconstruction by tissue engineering | |
CA3119936A1 (en) | Composition for reconstituting human skin tissue having hair follicles, human skin tissue model animal, and production method thereof | |
JP2018510643A (ja) | 皮膚同等物及び使用 | |
WO2002040645A2 (de) | Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung | |
CN111417717A (zh) | 真皮乳头和毛囊等同物的体外制备方法 | |
Compton | Cultured Epithelial Autografts: Skin Regeneration and Wound Healing A Long-Term Biospy Study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130208 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140207 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150213 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160211 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170209 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180312 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190211 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200226 Year of fee payment: 13 |